Abstract
Burkitt’s lymphoma is an aggressive B-cell lymphoma with rapid proliferative index, which makes it disseminate easily to distal sites, especially to bone marrow and the central nerve system. We report here a 22-year-old woman with Burkitt’s lymphoma involving multiple organs, including kidneys, breasts, left ovary, and bone marrow at the time of diagnosis. The patient responded well to intensive chemotherapy before the onset of retro-orbital pain, vomiting, and photophobia. The contrast-enhanced T1-weighted image in a second magnetic resonance image (MRI) showed a 2 × 1.9 cm mass in her left cavernous sinus that was not found in her initial MRI. Central nervous system (CNS)-directed high-dose chemotherapy and whole-brain radiation could not change the final failed treatment outcome caused by the cavernous sinus involvement disseminating to her entire CNS. Further study should provide well-designed therapeutic strategies to Burkitt’s patients with cavernous sinus involvement.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Ferry JA. Burkitt’s lymphoma: clinicopathologic features and differential diagnosis. Oncologist. 2006;11:375–83. doi:10.1634/theoncologist.11-4-375.
Wang ES, et al. Intensive chemotherapy with cyclophosphamide, doxorubicin, high-dose methotrexate/ifosfamide, etoposide, and high-dose cytarabine (CODOX-M/IVAC) for human immunodeficiency virus-associated Burkitt lymphoma. Cancer. 2003;98:1196–205. doi:10.1002/cncr.11628.
Blum KA, Lozanski G, Byrd JC. Adult Burkitt leukemia and lymphoma. Blood. 2004;104:3009–20. doi:10.1182/blood-2004-02-0405.
Salzburg J, et al. Prevalence, clinical pattern, and outcome of CNS involvement in childhood and adolescent non-Hodgkin’s lymphoma differ by non-Hodgkin’s lymphoma subtype: a Berlin-Frankfurt-Munster Group Report. J Clin Oncol. 2007;25:3915–22. doi:10.1200/JCO.2007.11.0700.
Magrath I, et al. Adults and children with small non-cleaved-cell lymphoma have a similar excellent outcome when treated with the same chemotherapy regimen. J Clin Oncol. 1996;14:925–34.
Thomas DA, et al. Hyper-CVAD program in Burkitt’s-type adult acute lymphoblastic leukemia. J Clin Oncol. 1999;17:2461–70.
Lee EJ, et al. Brief-duration high-intensity chemotherapy for patients with small noncleaved-cell lymphoma or FAB L3 acute lymphocytic leukemia: results of cancer and leukemia group B study 9251. J Clin Oncol. 2001;19:401–22.
Kaplan LD, et al. For the National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group. low-dose compared with standard-dose m-BACOD chemotherapy for non-Hodgkin’s lymphoma associated with human immunodeficiency virus infection. N Engl J Med. 1997;336:1641–8. doi:10.1056/NEJM199706053362304.
Lister TA, et al. Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin’s disease: cotswolds meeting. J Clin Oncol. 1989;7:1630–6.
Shipp MA, et al. International non-Hodgkin’s lymphoma prognostic factors project: a predictive model for aggressive non-Hodgkin’s lymphoma. N Engl J Med. 1993;329:987–94. doi:10.1056/NEJM199309303291402.
Thomas DA, et al. Chemoimmunotherapy with hyper-CVAD plus rituximab for the treatment of adult Burkitt and Burkitt-type lymphoma or acute lymphoblastic leukemia. Cancer. 2006;106:1569–80. doi:10.1002/cncr.21776.
Ampil FL, et al. Cavernous sinus involvement by extramedullary plasmacytoma of the sphenoid sinus. an argument for the use of adjuvant chemotherapy. Leuk Lymphoma. 2002;43:2037–40.
Vande Broek I, et al. Extramedullary plasmacytoma of the cavernous sinus. Leuk Lymphoma. 2002;43:1691–3. doi:10.1080/1042819021000003054.
Gozzetti A, et al. Multiple myeloma involving the cavernous sinus: a report of 3 cases and response to bortezomib. Clin Lymphoma Myeloma. 2007;7:376–8. doi:10.3816/CLM.2007.n.017.
Sanjeevi A, Krishnan J, Bailey PR, Catlett J. Extranodal marginal zone B-cell lymphoma of malt type involving the cavernous sinus. Leuk Lymphoma. 2001;42:1133–7. doi:10.3109/10428190109097736.
Huisman TA, et al. Burkitt’s lymphoma with bilateral cavernous sinus and mediastinal involvement in a child. Pediatr Radiol. 2003;33:719–21. doi:10.1007/s00247-003-1010-x.
Vaphiades MS, Lee AG. Burkitt lymphoma presenting with gingival pain and a cavernous sinus syndrome in an adult. J Neuroophthalmol. 2005;25:249–50. doi:10.1097/01.wno.0000177294.14351.6c.
Kasamon YL, Swinnen LJ. Treatment advances in adult Burkitt lymphoma and leukemia. Curr Opin Oncol. 2004;16:429–35. doi:10.1097/00001622-200409000-00003.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Chen, ZY., Wu, B. & Yin, JL. Intensive chemotherapy failure in Burkitt’s lymphoma with cavernous sinus involvement. Med Oncol 27, 327–331 (2010). https://doi.org/10.1007/s12032-009-9213-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12032-009-9213-0